Emerald Mutual Fund Advisers Trust’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34M | Buy |
405,651
+33,954
| +9% | +$2.84M | 2.07% | 6 |
|
|
2025
Q1 | $26.6M | Buy |
371,697
+3,123
| +0.8% | +$223K | 1.88% | 7 |
|
|
2024
Q4 | $16.6M | Buy |
368,574
+135,566
| +58% | +$6.09M | 1.01% | 39 |
|
|
2024
Q3 | $11.8M | Sell |
233,008
-8,091
| -3% | -$409K | 0.61% | 69 |
|
|
2024
Q2 | $9.84M | Buy |
241,099
+9,338
| +4% | +$381K | 0.52% | 70 |
|
|
2024
Q1 | $9.92M | Buy |
231,761
+30,435
| +15% | +$1.3M | 0.52% | 82 |
|
|
2023
Q4 | $8.1M | Hold |
201,326
| – | – | 0.43% | 92 |
|
|
2023
Q3 | $5.94M | Buy |
+201,326
| New | +$5.94M | 0.36% | 100 |
|